Company Filing History:
Years Active: 1997-2016
Title: Arthur O Tzianabos: Innovator in Immunomodulation
Introduction
Arthur O Tzianabos is a notable inventor based in Reading, MA (US). He has made significant contributions to the field of immunology, particularly in the development of zwitterionic immunomodulators. With a total of 9 patents to his name, Tzianabos has focused on methods and products that address asthma and allergic conditions.
Latest Patents
Among his latest patents is the invention of zwitterionic immunomodulators for the treatment of asthma and allergy. This patent outlines methods and products that utilize naturally occurring and synthetic zwitterionic polymers. These polymers have been found to induce T regulatory (Treg) cells and exert immunosuppressive effects both in vitro and in vivo. Another significant patent involves a method for the overexpression of zwitterionic polysaccharides. This invention provides methods for producing and selecting new mutant strains that express specific capsular polysaccharides. It also includes improved methods for the purification of these polysaccharides, particularly immunomodulatory capsular polysaccharide A (PSA), in high yield.
Career Highlights
Arthur O Tzianabos has worked with prestigious institutions such as Brigham and Women's Hospital, Inc. and Bingham and Women's Hospital. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Tzianabos has collaborated with esteemed colleagues, including Dennis L Kasper and Andrew B Onderdonk. These collaborations have further enriched his research and innovations in immunology.
Conclusion
Arthur O Tzianabos stands out as a prominent inventor in the field of immunomodulation, with a focus on developing innovative solutions for asthma and allergies. His contributions continue to impact the scientific community and improve health outcomes.